Why the study?
The effects of MMPs and TIMPs expressions on outcomes in patients with constrictive pericarditis undergoing pericardiectomy remained unclear.
Does a high level of MMP9 predict postoperative complications in patients with constrictive pericarditis undergoing pericardiectomy?
Cohort (n=22)
No
Does a high level of MMP9 predict postoperative complications in patients with constrictive pericarditis undergoing pericardiectomy?
Odds Ratio: 27.096 (95% CI 1.166–629.886)
Absolute Event Rate: 81.8% vs 9.1%
p-value: p=0.040
High levels of MMP9 in the pericardium are associated with an increased risk of postoperative complications following pericardiectomy for constrictive pericarditis.
High pericardial MMP9 may flag higher complication risk after pericardiectomy; hypothesis-generating and requires validation before clinical use.
Background The effects of matrix metalloproteases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) expressions on the patients with constrictive pericarditis undergoing pericardiectomy remain unclear. This study explored the associations of MMPs and TIMPs expressions with postoperative outcomes in these patients. Methods Pericardial specimens were obtained during pericardiectomy from the patients with constrictive pericarditis. The levels of MMP1, MMP2, MMP9 and TIMP1 in pericardium were analyzed by quantitative real-time polymerase chain reaction. The enrolled patients were divided into two groups according to the optimal cutoff value of gene expression predicting postoperative complications. Postoperative outcomes were compared between the two groups. Binary logistic regression analysis was performed to determine the degree of contribution of gene expression on postoperative outcomes. Results A total of 22 patients and their pericardial specimens were included. The level of MMP9 was significantly associated with postoperative complications and the optimal cutoff value predicting postoperative complications was 3.67. The patients with low level of MMP9 (< 3.67) had lower incidence of postoperative complications (P = 0.002), shorter postoperative intensive care unit (P = 0.040) and hospital stay (P = 0.043) in comparison to those with high level of MMP9 (≥ 3.67). Binary logistic regression analysis showed that high level of MMP9 increased risk of postoperative complications (OR, 27.096, 95%CI 1.166-629.886, P = 0.040). Conclusions High level of MMP9 in the pericardium was associated with poor postoperative outcomes and was the independent risk factor of postoperative complications. The level of MMP9 could be used as a potential marker for prediction of surgical outcomes.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2021) conducted a cohort in Constrictive pericarditis (n=22). High pericardial MMP9 expression (≥ 3.67) vs. Low pericardial MMP9 expression (< 3.67) was evaluated on Postoperative complications (OR 27.096, 95% CI 1.166-629.886, p=0.040).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: